We are live on ! Find out more
MDVX

Medovex Corp. Common Stock
MDVX

Delisted

MDVX was delisted on the 15th of November, 2017.

0 hedge funds and large institutions have $0 invested in Medovex Corp. Common Stock in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.85% less ownership

Funds ownership: 0.85%0% (-0.85%)

100% less funds holding

Funds holding: 80 (-8)

100% less capital invested

Capital invested by funds: $199K → $0 (-$199K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
Holders Change
-8
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
8
Calls
Puts
Net Calls
Net Calls Change

MDVX Hedge Fund Activity: Q4 2017 in Review

0 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q4 2017, worth a combined $0 — down 100% from $199K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MDVX and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Meridian Investment Counsel, exiting entirely with an estimated $112K sold.

  • 0 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q4 2017, down from 8 in Q3 2017.
  • Funds reported $0 of Medovex Corp. Common Stock stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Medovex Corp. Common Stock positions in Q4 2017 and 8 closed out, a net change of -8 holders.
  • The largest Medovex Corp. Common Stock seller in Q4 2017 was Meridian Investment Counsel, an estimated $112K sold.

Based on aggregated 13F filings for Q4 2017.